L-DOPA-induced modulation of GABA and glutamate release in substantia nigra pars reticulata in a rodent model of Parkinson's disease.
Ochi
Mayumi
M
Pharmaceutical Research Institute, Kyowa Hakko Kogyo Co., Nagaizumi, Sunto, Shizuoka 411-8731, Japan.
Shiozaki
Shizuo
S
Kase
Hiroshi
H
D000818:Animals; D018698:Glutamic Acid / Q000378:metabolism*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D016627:Oxidopamine; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000187:drug effects* / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
D018698:Glutamic Acid; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D016627:Oxidopamine